查看购物车
  • Traditional Chinese
  • English
  • Japanese
体外膜氧合（ECMO）设备市场规模、份额和成长分析（按组件、模式、患者年龄层、应用、最终用户和地区划分）—2025-2032年产业预测
市场调查报告书
商品编码
1865232

体外膜氧合（ECMO）设备市场规模、份额和成长分析（按组件、模式、患者年龄层、应用、最终用户和地区划分）—2025-2032年产业预测

Extracorporeal Membrane Oxygenation Machine Market Size, Share, and Growth Analysis, By Component, By Modality (Veno-Venous, Veno-Arterial ), By Patient Age Group, By Application, By End-User, By Region - Industry Forecast 2025-2032
出版日期: | 出版商: SkyQuest | 英文 197 Pages | 商品交期: 3-5个工作天内

价格
简介目录

全球体外膜氧合（ECMO）市场规模预计在 2023 年达到 3.114 亿美元，从 2024 年的 3.2822 亿美元增长到 2032 年的 4.999 亿美元，在预测期（2025-2032 年）内复合年增长率为 5.4%。

随着体外膜氧合（ECMO）这项关键技术在治疗常规治疗方法无效的严重心臟衰竭衰竭方面发挥至关重要的作用，全球ECMO设备市场正稳步成长。加护治疗基础设施的进步、心肺疾病盛行率的上升以及ECMO在临床实践中更广泛的应用，都推动了市场需求的成长。诸如便携性提升、生物相容性材料的使用以及整合监测系统等创新技术即将问世，这将进一步增强ECMO在紧急情况下的应用。专业ECMO中心的建立和训练有素的多学科团队的组成也推动了ECMO的进一步普及。然而，ECMO仍面临许多挑战，包括设备高成本、熟练专业人员短缺、ECMO管理复杂以及报销和监管方面的不确定性，尤其是在新兴市场，这些都可能阻碍ECMO的广泛应用。

推动全球体外膜氧合（ECMO）市场发展的因素

全球体外膜氧合（ECMO）设备市场的主要驱动因素之一是呼吸系统和心臟疾病的日益普遍，这些疾病需要先进的生命维持系统。急性呼吸窘迫症候群（ARDS）、心臟衰竭和重症肺炎等疾病发生率的上升，推动了医疗机构对ECMO技术的需求激增。此外，ECMO技术的进步，例如可携式系统的改进和疗效的提高，也促进了其在加护治疗领域的应用。人们对ECMO在严重健康危机中挽救生命的益处的认识不断提高，也显着促进了市场的扩张。

全球体外膜氧合（ECMO）市场阻碍因素

全球体外膜氧合（ECMO）设备市场的主要阻碍因素是ECMO系统及其相关组件的高成本。采购、维护和营运所需的大量资金投入，对医疗机构而言构成重大障碍，尤其是在预算和资源有限的发展中地区。此外，缺乏能够操作这些先进设备的训练有素的医护人员，也会阻碍ECMO的普及应用，导致其利用率不足。同时，监管方面的挑战以及人力资源发展的复杂性，也构成了额外的障碍，可能会减缓全球各地不同医疗机构的市场成长和普及速度。

全球体外膜氧合（ECMO）市场趋势

全球体外膜氧合（ECMO）设备市场正呈现出高度便携、易于操作的系统发展的显着趋势。製造商致力于研发紧凑轻便的ECMO设备，使其能够在传统加护病房之外的场所使用，从而在规模较小的医疗机构和患者转运过程中实现有效治疗。这些进步缩短了设备安装时间，提高了ECMO治疗的可近性，尤其是在农村和资源匮乏的地区。随着医疗机构日益重视设备的便携性和易用性，市场正在转型以满足不断变化的患者照护需求，最终改善临床疗效并提高营运效率。

目录

介绍

  • 调查目标
  • 调查范围
  • 定义

调查方法

  • 资讯收集
  • 二手资料和一手资料方法
  • 市场规模预测
  • 市场假设与限制

执行摘要

  • 全球市场展望
  • 供需趋势分析
  • 细分市场机会分析

市场动态与展望

  • 市场概览
  • 市场规模
  • 市场动态
    • 驱动因素和机会
    • 限制与挑战
  • 波特分析

关键市场考察

  • 关键成功因素
  • 竞争程度
  • 关键投资机会
  • 市场生态系统
  • 市场吸引力指数（2024）
  • PESTEL 分析
  • 总体经济指标
  • 价值链分析
  • 定价分析
  • 技术评估
  • 监管环境
  • 原料分析

体外膜氧合（ECMO）设备市场规模（依组件划分）及复合年增长率（2025-2032 年）

  • 市场概览
  • 泵浦
  • 氧合设备
  • 控制器
  • 套管和导管套装
  • 配件和耗材

体外膜氧合（ECMO）设备市场规模：依模式和复合年增长率（2025-2032 年）划分

  • 市场概览
  • 静脉-静脉（VV）
  • 静脉-动脉（VA）
  • 动静脉（AV）

体外膜氧合（ECMO）设备市场规模：依病患年龄层及复合年增长率（2025-2032 年）划分

  • 市场概览
  • 新生
  • 孩子们
  • 成人

体外膜氧合（ECMO）设备市场规模：依应用及复合年增长率（2025-2032）划分

  • 市场概览
  • 呼吸系统疾病
  • 心臟病
  • 体外心肺復苏术（ECPR）

体外膜氧合（ECMO）设备市场规模（依最终用户划分）及复合年增长率（2025-2032 年）

  • 市场概览
  • 医院（加加护病房/心臟监护室）
  • 专科诊所
  • 紧急医疗服务

体外膜氧合（ECMO）设备市场规模及复合年增长率（2025-2032）

  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 德国
    • 西班牙
    • 法国
    • 英国
    • 义大利
    • 其他欧洲地区
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 亚太其他地区
  • 拉丁美洲
    • 巴西
    • 其他拉丁美洲地区
  • 中东和非洲
    • 海湾合作委员会国家
    • 南非
    • 其他中东和非洲地区

竞争资讯

  • 前五大公司对比
  • 主要企业的市场定位（2024 年）
  • 主要市场参与者所采取的策略
  • 近期市场趋势
  • 公司市占率分析（2024 年）
  • 主要企业简介
    • 公司详情
    • 产品系列分析
    • 依业务板块进行公司股票分析
    • 2022-2024年营收年比比较

主要企业简介

  • Medtronic plc
  • Getinge AB
  • LivaNova PLC
  • Terumo Cardiovascular Corporation
  • Nipro Corporation
  • Eurosets Srl
  • Maquet Holding（Getinge Group）
  • CytoSorbents Corporation
  • Medos Medizintechnik AG
  • Microport Scientific Corporation
  • Philips Healthcare（ECLS division）
  • Edwards Lifesciences Corporation
  • Xenios AG
  • Saranas Inc.
  • Oxygen Plus Medical Systems
  • Hemovent GmbH
  • Abiomed Inc.
  • Boston Scientific Corporation
  • Smiths Medical（ICU Life Support Division）
  • Baxter International Inc.

结论与建议

简介目录
Product Code: SQMIG35A3132

Global Extracorporeal Membrane Oxygenation Machine Market size was valued at USD 311.4 million in 2023 and is poised to grow from USD 328.22 million in 2024 to USD 499.9 million by 2032, growing at a CAGR of 5.4% during the forecast period (2025-2032).

The global market for extracorporeal membrane oxygenation (ECMO) machines is experiencing steady growth as this vital technology becomes integral in managing severe cardiac and respiratory failures when conventional treatments fall short. Factors fueling demand include advancements in critical care infrastructures, rising prevalence of cardiopulmonary diseases, and broader acceptance of ECMO in clinical practices. Innovations such as increased portability, use of biocompatible materials, and integrated monitoring systems are on the horizon, enhancing usability in emergency scenarios. The establishment of specialized ECMO centers and trained multidisciplinary teams is further propelling adoption. However, challenges remain, including the high costs of machines, a shortage of skilled professionals, complexities in managing ECMO, and uncertainties in reimbursement and regulation, particularly in emerging markets, which may hinder broader implementation.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Extracorporeal Membrane Oxygenation Machine market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Extracorporeal Membrane Oxygenation Machine Market Segments Analysis

Global Extracorporeal Membrane Oxygenation Machine Market is segmented by Component, Modality, Patient Age Group, Application, End-User and region. Based on Component, the market is segmented into Pumps, Oxygenators, Controllers, Cannula & Tubing Sets and Accessories & Consumables. Based on Modality, the market is segmented into Veno-Venous (VV), Veno-Arterial (VA) and Arterio-Venous (AV). Based on Patient Age Group, the market is segmented into Neonates, Pediatrics and Adults. Based on Application, the market is segmented into Respiratory Disorders, Cardiac Conditions and Extracorporeal Cardiopulmonary Resuscitation (ECPR). Based on End-User, the market is segmented into Hospitals (ICU / Cardiac Care Units), Specialty Clinics and Emergency Medical Services. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Extracorporeal Membrane Oxygenation Machine Market

One of the key market drivers for the global extracorporeal membrane oxygenation (ECMO) machine market is the increasing prevalence of respiratory and cardiac diseases that require advanced life-support systems. As the incidence of conditions such as acute respiratory distress syndrome (ARDS), heart failure, and severe pneumonia rises, the demand for ECMO technology has surged in healthcare institutions. Additionally, advancements in ECMO technology, including improvements in portable systems and increased efficacy, have bolstered its adoption in critical care settings. This growing recognition of ECMO's role in saving lives during severe health crises significantly contributes to the expansion of the market.

Restraints in the Global Extracorporeal Membrane Oxygenation Machine Market

A significant restraint in the global extracorporeal membrane oxygenation (ECMO) machine market is the high cost of ECMO systems and their associated components. The substantial financial investment required for procurement, maintenance, and operation can be a major hurdle for healthcare facilities, particularly in developing regions with limited budgets and resources. Additionally, the shortage of trained healthcare professionals to operate these sophisticated machines can hinder their implementation, leading to underutilization. Furthermore, regulatory challenges and the complexity involved in training personnel pose additional barriers that could slow market growth and adoption rates across various healthcare settings worldwide.

Market Trends of the Global Extracorporeal Membrane Oxygenation Machine Market

The Global Extracorporeal Membrane Oxygenation (ECMO) Machine market is witnessing a significant trend toward the development of portable and user-friendly systems. Manufacturers are focusing on creating compact, lightweight ECMO machines that facilitate their use beyond traditional intensive care units, enabling effective treatment even in smaller healthcare facilities or during patient transport. These advancements lead to quicker setup times, thereby enhancing accessibility to ECMO therapy, particularly in rural and resource-limited environments. As healthcare providers increasingly prioritize mobility and ease of use, the market is transforming to meet the evolving needs of patient care, ultimately improving clinical outcomes and operational efficiency.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2024
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis
  • Technology Assessment
  • Regulatory Landscape
  • Raw Material Analysis

Global Extracorporeal Membrane Oxygenation Machine Market Size by Component & CAGR (2025-2032)

  • Market Overview
  • Pumps
  • Oxygenators
  • Controllers
  • Cannula & Tubing Sets
  • Accessories & Consumables

Global Extracorporeal Membrane Oxygenation Machine Market Size by Modality & CAGR (2025-2032)

  • Market Overview
  • Veno-Venous (VV)
  • Veno-Arterial (VA)
  • Arterio-Venous (AV)

Global Extracorporeal Membrane Oxygenation Machine Market Size by Patient Age Group & CAGR (2025-2032)

  • Market Overview
  • Neonates
  • Pediatrics
  • Adults

Global Extracorporeal Membrane Oxygenation Machine Market Size by Application & CAGR (2025-2032)

  • Market Overview
  • Respiratory Disorders
  • Cardiac Conditions
  • Extracorporeal Cardiopulmonary Resuscitation (ECPR)

Global Extracorporeal Membrane Oxygenation Machine Market Size by End-User & CAGR (2025-2032)

  • Market Overview
  • Hospitals (ICU / Cardiac Care Units)
  • Specialty Clinics
  • Emergency Medical Services

Global Extracorporeal Membrane Oxygenation Machine Market Size & CAGR (2025-2032)

  • North America (Component, Modality, Patient Age Group, Application, End-User)
    • US
    • Canada
  • Europe (Component, Modality, Patient Age Group, Application, End-User)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Component, Modality, Patient Age Group, Application, End-User)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Component, Modality, Patient Age Group, Application, End-User)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Component, Modality, Patient Age Group, Application, End-User)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2024
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2024
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

  • Medtronic plc
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Getinge AB
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • LivaNova PLC
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Terumo Cardiovascular Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Nipro Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Eurosets S.r.l.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Maquet Holding (Getinge Group)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • CytoSorbents Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Medos Medizintechnik AG
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Microport Scientific Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Philips Healthcare (ECLS division)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Edwards Lifesciences Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Xenios AG
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Saranas Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Oxygen Plus Medical Systems
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Hemovent GmbH
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Abiomed Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Boston Scientific Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Smiths Medical (ICU Life Support Division)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Baxter International Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations